Note: This document has been translated from the Japanese original for reference purpose only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.
May 8, 2025
Trade name: Noevir Holdings Co., Ltd.
Listing: Tokyo Stock Exchange, Prime Market (Securities Code: 4928) URL: https://www.noevirholdings.co.jp/
Representative: Takashi Okura, President and CEO Contact: Junya Baba, General Manager, Accounting
Tel. +81-78-303-5121
Submission of semi-annual securities report: May 13, 2025 Date of commencement of dividend payments: -Supplemental materials for the financial results prepared: Yes
Results briefing for the reporting period held: Yes (for institutional investors and analysts)
(Amounts under one million yen have been rounded down)
Operating results for the first six months of the fiscal year ending September 30, 2025 (October 1, 2024 to March 31, 2025)
Consolidated operating results
(Millions of yen; percentage figures denote year-on-year change)
Net sales
Operating income
Ordinary income
Net income attributable to owners of the parent
Six months ended March 31, 2025
32,037
1.3 %
5,712
(7.3) %
6,025
(3.5) %
2,641
1.7 %
Six months ended March 31, 2024
31,625
2.4 %
6,165
7.2 %
6,246
7.5 %
2,597
(2.8) %
Note: Comprehensive income:
Six months ended March 31, 2025: 2,637 million yen [(14.9)%]
Six months ended March 31, 2024: 3,100 million yen [1.7%]
EPS (Yen)
Diluted EPS (Yen)
Six months ended March 31, 2025
77.34
-
Six months ended March 31, 2024
76.06
-
Consolidated financial position
(Millions of yen)
Total assets
Net assets
Equity ratio (%)
As of March 31, 2025
72,702
48,859
66.5
As of September 30, 2024
76,471
53,906
69.9
[Reference] Equity:
As of March 31, 2025: 48,320 million yen
As of September 30, 2024: 53,477 million yen
Cash dividends
(Yen)
Annual dividends
1st quarter
2nd quarter
3rd quarter
Year-end
Total
Fiscal year ended September 30, 2024
-
0.00
-
225.00
225.00
Fiscal year ending September 30, 2025
-
0.00
Fiscal year ending September 30, 2025 (forecast)
-
225.00
225.00
Note: Revisions from the most recently announced dividend forecast: None
Consolidated earnings forecasts for the fiscal year ending September 30, 2025 (October 1, 2024 to September 30, 2025)
(Millions of yen; percentage figures denote year-on-year change)
Net sales | Operating | income | Ordinary | income | Net income attributable to owners of the parent | EPS (Yen) | |||
Full year | 64,000 | 0.3% | 11,500 | 0.7% | 11,700 | 0.9% | 8,000 | 0.4% | 234.22 |
Note: Revisions from the most recently announced consolidated earnings forecast: None
* Notes
Significant changes in the scope of consolidation during the period: None
Special accounting treatment for preparation of semi-annual consolidated financial statements: None
Changes in accounting policies, changes in accounting estimates, and restatement
Changes associated with revision in accounting standards: Yes
Other changes: None
Changes in accounting estimates: None
Restatement: None
Shares outstanding (common stock)
Shares outstanding (including treasury stock) As of March 31, 2025: 34,156,623
As of September 30, 2024: 34,156,623
Treasury shares outstanding As of March 31, 2025: 416
As of September 30, 2024: 416
Average shares outstanding over quarter
Six months ended March 31, 2025: 34,156,207
Six months ended March 31, 2024: 34,156,353
Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm.
Explanation regarding the appropriate use of business performance forecasts
Forward-looking statements included in these materials, such as forecasts of business performance, are based on information known to the Company's management as of the time of writing, and reflect judgments believed to be reasonable on the basis of that information. There is, therefore, a possibility that actual business performance figures will differ substantially from our forecasts as a result of changes in the economic situation and other unforeseeable factors. Please refer to "(3) Estimates and forecasts pertaining to future plans and business results" under "1. Operating results and financial information" on page 5 of the Attached Material.
Contents of the Attached Material
Operating results and financial information 4
Operating results for the first six months of the fiscal year ending September 30, 2025 4
Financial position as of March 31, 2025 4
Estimates and forecasts pertaining to future plans and business results 5
Semi-annual consolidated financial statements and notes 6
Semi-annual consolidated balance sheets 6
Semi-annual consolidated statements of income and comprehensive income 8
Semi-annual consolidated statements of cash flows 10
Notes to semi-annual consolidated financial statements 11
(Note on assumptions for going concern) 11
(Note on significant changes in the amount of shareholders' equity) 11
(Note on changes in accounting policies) 11
(Note on segment information) 12
Operating results and financial information
Operating results for the first six months of the fiscal year ending September 30, 2025 Consolidated operating results for the first six months of the fiscal year ending September 30, 2025 (October 1, 2024 to March 31, 2025)
Six months ended
March 31, 2024
Six months ended
March 31, 2025
Change (Millions of yen)
Change (%)
Net sales (Millions of yen)
% of Total
Net sales (Millions of yen)
% of Total
Net sales
31,625
100.0
32,037
100.0
411
1.3
Cosmetics
25,103
79.4
25,442
79.4
339
1.4
Pharmaceuticals & Health Food
5,498
17.4
5,596
17.5
98
1.8
Other
1,024
3.2
998
3.1
(25)
(2.5)
Six months ended March 31, 2024
Six months ended March 31, 2025
Change (Millions of yen)
Change (%)
Amount (Millions of yen)
% of Net sales
Amount (Millions of yen)
% of Net sales
Operating income
6,165
19.5
5,712
17.8
(453)
(7.3)
Ordinary income
6,246
19.8
6,025
18.8
(221)
(3.5)
Net income attributable to owners of the parent
2,597
8.2
2,641
8.2
43
1.7
During the first six months of fiscal 2025 (October 1, 2024 to March 31, 2025), economic trends remained uncertain, although some signs of gradual recovery were observed.
In this environment, the Company is working to realize the concept of its medium- to long-term strategy: "Realizing steady corporate growth by securing sustainability in every Group business segment."
As a result, net sales for the first six months of fiscal 2025 came to 32,037 million yen (up 1.3% year on year), operating income was 5,712 million yen (down 7.3%), ordinary income was 6,025 million yen (down 3.5%), and net income attributable to owners of the parent came to 2,641 million yen (up 1.7%).
In the Cosmetics segment, net sales totaled 25,442 million yen (up 1.4% year on year), and segment income came to 6,413 million yen (down 1.4%).
In the Pharmaceuticals & Health Food segment, net sales totaled 5,596 million yen (up 1.8% year on year), and segment income came to 425 million yen (down 37.8%).
In the Other segment, net sales totaled 998 million yen (down 2.5% year on year), and segment income came to 101 million yen (down 32.3%).
Financial position as of March 31, 2025
Total assets as of March 31, 2025 stood at 72,702 million yen, a decrease of 3,769 million yen from the previous fiscal year-end. This was mainly due to a decrease in cash and deposits of 5,423 million yen and an increase in land of 1,417 million yen.
Total liabilities came to 23,842 million yen, an increase of 1,277 million yen from the previous fiscal year-end. This mainly reflected an increase in income tax payable of 1,678 million yen and a decrease in net defined benefit liability of 548 million yen.
Net assets came to 48,859 million yen, a decrease of 5,047 million yen from the previous fiscal year-end.
This was primarily attributable to a decrease in retained earnings of 5,043 million yen, due to the payment of 7,685 million yen in dividends at the previous fiscal year-end, which was partly offset by net income attributable to owners of the parent of 2,641 million yen.
As a result, the equity ratio stood at 66.5%.
(Consolidated cash flows)
Cash and cash equivalents (hereinafter, "cash") on a consolidated basis as of the end of the period under review stood at 23,592 million yen, a decrease of 5,413 million yen compared with the previous fiscal year-end.
The status of each cash flow together with the factors contributing to their increase or decrease for the first six months of fiscal 2025 are presented as follows.
(Cash flows from operating activities)
Net cash provided by operating activities amounted to 3,986 million yen (compared with an inflow of 6,202 million yen in the corresponding period of the previous fiscal year). The main item increasing cash was 6,112 million yen in income before income taxes, and the main item decreasing cash was 1,582 million yen in net income taxes paid.
(Cash flows from investing activities)
Net cash used in investing activities came to 1,769 million yen (compared with an inflow of 2,156 million yen in the corresponding period of the previous fiscal year). The principal cash outflow was 1,559 million yen for purchase of property, plant and equipment.
(Cash flows from financing activities)
Net cash used in financing activities came to 7,722 million yen (compared with an outflow of 7,560 million yen in the corresponding period of the previous fiscal year). This was mainly due to the payment of 7,679 million yen in dividends.
Estimates and forecasts pertaining to future plans and business results
The consolidated business performance forecasts for the full year ending September 30, 2025, announced on November 8, 2024, remain unchanged.